BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 29969855)

  • 1. Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders.
    Fukui H; Xu X; Miwa H
    J Neurogastroenterol Motil; 2018 Jul; 24(3):367-386. PubMed ID: 29969855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of gut microbiota-derived signals in the regulation of gastrointestinal motility.
    Zheng Z; Tang J; Hu Y; Zhang W
    Front Med (Lausanne); 2022; 9():961703. PubMed ID: 35935766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Brain-Gut-Microbiota Axis].
    Lee A; Lee JY; Jung SW; Shin SY; Ryu HS; Jang SH; Kwon JG; Kim YS
    Korean J Gastroenterol; 2023 Apr; 81(4):145-153. PubMed ID: 37096434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders.
    Singh R; Zogg H; Ghoshal UC; Ro S
    Front Pharmacol; 2022; 13():808195. PubMed ID: 35145413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritable bowel syndrome, the microbiota and the gut-brain axis.
    Raskov H; Burcharth J; Pommergaard HC; Rosenberg J
    Gut Microbes; 2016 Sep; 7(5):365-83. PubMed ID: 27472486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Concepts of the Interplay Between the Gut Microbiota and the Enteric Nervous System in the Control of Motility.
    Vicentini FA; Fahlman T; Raptis SG; Wallace LE; Hirota SA; Sharkey KA
    Adv Exp Med Biol; 2022; 1383():55-69. PubMed ID: 36587146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of gut microbiota in association between GLP-1/GLP-1 receptor expression and gastrointestinal motility.
    Yang M; Fukui H; Eda H; Xu X; Kitayama Y; Hara K; Kodani M; Tomita T; Oshima T; Watari J; Miwa H
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G367-G373. PubMed ID: 28154011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Brain-Gut-Microbiotal Axis: A framework for understanding functional GI illness and their therapeutic interventions.
    Tait C; Sayuk GS
    Eur J Intern Med; 2021 Feb; 84():1-9. PubMed ID: 33423906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders.
    Karakan T; Ozkul C; Küpeli Akkol E; Bilici S; Sobarzo-Sánchez E; Capasso R
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33513791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome.
    Chen M; Ruan G; Chen L; Ying S; Li G; Xu F; Xiao Z; Tian Y; Lv L; Ping Y; Cheng Y; Wei Y
    Front Endocrinol (Lausanne); 2022; 13():817100. PubMed ID: 35250873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microbiota-gut-brain axis in functional gastrointestinal disorders.
    De Palma G; Collins SM; Bercik P
    Gut Microbes; 2014; 5(3):419-29. PubMed ID: 24921926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut hormones: emerging role in immune activation and inflammation.
    Khan WI; Ghia JE
    Clin Exp Immunol; 2010 Jul; 161(1):19-27. PubMed ID: 20408856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irritable bowel syndrome: a gut microbiota-related disorder?
    Bhattarai Y; Muniz Pedrogo DA; Kashyap PC
    Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G52-G62. PubMed ID: 27881403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Gut Microbiota in Neuroendocrine Regulation of Carbohydrate and Lipid Metabolism via the Microbiota-Gut-Brain-Liver Axis.
    Wang SZ; Yu YJ; Adeli K
    Microorganisms; 2020 Apr; 8(4):. PubMed ID: 32272588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
    Yu Y; Yang W; Li Y; Cong Y
    Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders.
    Shin A; Preidis GA; Shulman R; Kashyap PC
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):256-274. PubMed ID: 30153517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and indirect mechanisms by which the gut microbiota influence host serotonin systems.
    Legan TB; Lavoie B; Mawe GM
    Neurogastroenterol Motil; 2022 Oct; 34(10):e14346. PubMed ID: 35246905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome.
    Mishima Y; Ishihara S
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of gut microbiota via the gut-liver-brain axis in digestive diseases.
    Ding JH; Jin Z; Yang XX; Lou J; Shan WX; Hu YX; Du Q; Liao QS; Xie R; Xu JY
    World J Gastroenterol; 2020 Oct; 26(40):6141-6162. PubMed ID: 33177790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.